Association studies of transforming growth factor-β1 and Alzheimer's disease

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 139 B, Issue 1, 2005, Pages 38-41

  Dickson, M R ^a,b   Perry, R T ^a   Wiener, H ^a   Go, R C P ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Ryals Building   (United States)

Author keywords

Apolipoprotein; Cytokines; Neuroinflammation; TGFB1 +869 SNP; TGFB1 509 SNP

Indexed keywords

APOLIPOPROTEIN E4;

ADULT; AFRICAN AMERICAN; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FAMILY; GENE; GENE FUNCTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; PATHOGENESIS; POPULATION GENETICS; PRIORITY JOURNAL; SIBLING; SINGLE NUCLEOTIDE POLYMORPHISM; TGFB1 GENE;

AGED; ALZHEIMER DISEASE; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CYTOKINES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 27644511929     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30218     Document Type: Article

References (38)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, et al. 2000. Inflammation and Alzheimer's disease. Neurobiol Aging 21(3):383-421.
2. Araria-Goumidi L, Lambert JC, Mann DM, Lendon C, Frigard B, Iwatsubo T, Cottel D, Amouyel P, Chartier-Harlin MC. 2002. Association study of three polymorphisms of TGF-betal gene with Alzheimer's disease. J Neurol Neurosurg Psychiatry 73(1):62-64.
3. Blacker D, Haines JL, Rodes H, Terwedow H, Go RCP, Harrell LE, Perry RT, Bassett SS, Chase GA, Meyers D, et al. 1997. ApoE-4 and age at onset of Alzheimer's Disease: The NIMH Genestic Initiative. Neurology 48:139-147.
4. Blacker D, Bertram L, Saunders AJ, Moscarillo TJ, Albert MS, Wiener H, Perry RT, Collins JS, Harrell LE, Go RC, et al. 2003. Results of a high-resolution genome screen of 437 Alzheimer's disease families. Hum Mol Genet 12(1):23-32.
5. Buckwalter M, Pepper JP, Gaertner RF, Von Euw D, Lacombe P, Wyss-Coray T. 2002. Molecular and functional dissection of TGF-beta1-induced cerebrovascular abnormalities in transgenic mice. Ann NY Acad Sci 977:87-95.
6. Fillit H, Leveugle B. 1995. Disorders of the extracellular matrix and the pathogenesis of senile dementia of the Alzheimer's type. Lab Invest 72(3):249-253.
7. Forrester JS. 2004. Common ancestors: Chronic progressive diseases have the same pathogenesis. Clin Cardiol 27(4):186-190.
8. Gojova A, Brun V, Esposito B, Cottrez F, Gourdy P, Ardouin P, Tedgui A, Mallat Z, Groux H. 2003. Specific abrogation of transforming growth factor-beta signaling in T cells alters atherosclerotic lesion size and composition in mice. Blood 102(12):4052-4058.
9. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, Metcalfe JC, Carter ND, Spector TD. 1999. Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8(1):93-97.
10. Gray CW, Patel AJ. 1993. Regulation of beta-amyloid precursor protein isoform mRNAs by transforming growth factor-beta 1 and interleukin-1 beta in astrocytes. Brain Res Mol Brain Res 19(3):251-256.
11. Harris-White ME, Chu T, Balverde Z, Sigel JJ, Flanders KC, Frautschy SA. 1998. Effects of transforming growth factor-beta (isoforms 1-3) on amyloid-beta deposition, inflammation, and cell targeting in organotypic hippocampal slice cultures. J Neurosci 18(24):10366-10374.
12. Hixson JE, Vernier DT. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J Lipid Res 31(3):545-548.
13. Horvath S, Wei E, Xu X, Palmer LJ, Baur M. 2001. Family-based association test method: age of onset traits and covariates. Genet Epidemiol 21(Suppl 1):S403-S408.
14. Iglesias-De La Cruz MC, Ruiz-Torres P, Alcami J, Diez-Marques L, Ortega-Velazquez R, Chen S, Rodriguez-Puyol M, Ziyadeh FN, Rodriguez-Puyol D. 2001. Hydrogen peroxide increases extracellular matrix mRNA through TGF-beta in human mesangial cells. Kidney Int 59(1): 87-95.
15. Kamboh MI. 2004. Molecular genetics of late-onset Alzheimer's disease. Ann Hum Genet 68(Pt 4):381-404.
16. LaDu MJ, Lukens JR, Reardon CA, Getz GS. 1997. Association of human, rat, and rabbit apolipoprotein E with beta-amyloid. J Neurosci Res 49(1):9-18.
17. Lahiri DK, Sambamurti K, Bennett DA. 2004. Apolipoprotein gene and its interaction with the environmentally driven risk factors: Molecular, genetic and epidemiological studies of Alzheimer's disease. Neurobiol Aging 25(5):651-660.
18. Lesne S, Docagne F, Gabriel C, Liot G, Lahiri DK, Buee L, Plawinski L, Delacourte A, MacKenzie ET, Buisson A, et al. 2003. Transforming growth factor-beta 1 potentiates amyloid-beta generation in astrocytes and in transgenic mice. J Biol Chem 278(20):18408-18418.
19. Libby P. 2001. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104(3):365-372.
20. Luedecking EK, DeKosky ST, Mehdi H, Ganguli M, Kamboh MI. 2000. Analysis of genetic polymorphisms in the transforming growth factor-beta1 gene and the risk of Alzheimer's disease. Hum Genet 106(5):565-569.
21. Lunetta KL, Faraone SV, Biederman J, Laird NM. 2000. Family-based tests of association and linkage that use unaffected sibs, covariates, and interactions. Am J Hum Genet 66(2):605-614.
22. Mantel N, Haenszel W. 1959. Statistical aspects of the analysis of data from retrospective studies of disease. J NCI 22:719-748.
23. Markesbery WR. 1999. The role of oxidative stress in Alzheimer disease. Arch Neurol 56(12):1449-1452.
24. Mattson MP, Barger SW, Furukawa K, Bruce AJ, Wyss-Coray T, Mark RJ, Mucke L. 1997. Cellular signaling roles of TGF beta, TNF alpha and beta APP in brain injury responses and Alzheimer's disease. Brain Res Rev 23(1-2):47-61.
25. Miyata M, Smith JD. 1996. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides. Nat Genet 14(1):55-61.
26. Monning U, Sandbrink R, Banati RB, Masters CL, Beyreuther K. 1994. Transforming growth factor beta mediates increase of mature transmembrane amyloid precursor protein in microglial cells. FEBS Lett 342(3):267-272.
27. Neve RL, McPhie DL, Chen Y. 2000. Alzheimer's disease: A dysfunction of the amyloid precursor protein(1). Brain Res 886(1-2):54-66.
28. Perry RT, Collins JS, Harrell LE, Acton RT, Go RC. 2001. Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am J Med Genet 105(4):332-342.
29. Poirier J. 2005. Apolipoprotein E, cholesterol transport and synthesis in sporadic Alzheimer's disease. Neurobiol Aging 26(3):355-361.
30. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, Schwartz JE, August P. 2000. Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA 97(7):3479-3784.
31. Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, Nieuwstraten P. 1988. The NINCDS-ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases. Neurology 38(3):359-364.
32. van der Wal EA, Gomez-Pinilla F, Cotman CW. 1993. Transforming growth factor-beta 1 is in plaques in Alzheimer and Down pathologies. Neuroreport 4(1):69-72.
33. Wang P, Yang G, Mosier DR, Chang P, Zaidi T, Gong YD, Zhao NM, Dominguez B, Lee KF, Gan WB, et al. 2005. Defective neuromuscular synapses in mice lacking amyloid precursor protein (APP) and APP-Like protein 2. J Neurosci 25(5):1219-1225.
34. Wilmer WA, Dixon CL, Hebert C, Lu L, Rovin BH. 2002. PPAR-alpha ligands inhibit H2O2-mediated activation of transforming growth factor-beta1 in human mesangial cells. Antioxid Redox Signal 4(6):877-884.
35. Wood NA, Thomson SC, Smith RM, Bidwell JL. 2000. Identification of human TGF-beta1 signal (leader) sequence polymorphisms by PCR-RFLP. J Immunol Methods 234(1-2):117-122.
36. Wyss-Coray T, Feng L, Masliah E, Ruppe MD, Lee HS, Toggas SM, Rockenstein EM, Mucke L. 1995. Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. Am J Pathol 147(1):53-67.
37. Yamada Y, Miyauchi A, Goto J, Takagi Y, Okuizumi H, Kanematsu M, Hase M, Takai H, Harada A, Ikeda K. 1998. Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women. J Bone Miner Res 13(10):1569-1576.
38. Zetterberg H, Andreasen N, Blennow K. 2004. Increased cerebrospinal fluid levels of transforming growth factor-betal in Alzheimer's disease. Neurosci Lett 367(2):194-196.